Epigenetic alterations are a hallmark of cancer. Changes in DNA methylation and histone modification can lead to the activation of oncogenes or the silencing of tumor suppressor genes. Environmental carcinogens, such as benzene and arsenic, have been linked to such epigenetic changes, highlighting the importance of studying epigenomics in the context of cancer risk assessment.
